Strategic selection of MDM2 inhibitors enhances the efficacy of FAK inhibition in mesothelioma based on TP53 genotype
by Xuerao Ning, Thảo Thi Thanh Nguyễn, Takao Morinaga, Yuji Tada, Hideaki Shimada, Kenzo Hiroshima, Naoto Yamaguchi, Masatoshi Tagawa Mesothelioma has characteristic genetic changes including inactivation of neurofibromatosis type 2 (NF2) and deletion of the INK4A/ARF regi...
🔗 Read more: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0343551
#News #Biology #Genetics #Policy #WorldNews #Politics #Academic
Edited
Comments
Log in to leave a comment.
No comments yet. Be the first to comment!